| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27808-235-01 | 27808-235 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 50 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-235-01) |
| 27808-236-01 | 27808-236 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 75 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-236-01) |
| 27808-237-01 | 27808-237 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 100 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-237-01) |
| 27808-238-01 | 27808-238 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 150 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-238-01) |
| 27808-239-01 | 27808-239 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 200 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-239-01) |
| 27808-240-01 | 27808-240 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 225 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-240-01) |
| 27808-241-01 | 27808-241 | HUMAN PRESCRIPTION DRUG | Pregabalin | Pregabalin | CAPSULE | ORAL | 20220201 | N/A | ANDA | ANDA214322 | Tris Pharma Inc | PREGABALIN | 300 mg/1 | 90 CAPSULE in 1 BOTTLE (27808-241-01) |